Dr. P. Vijaya secured one of the 18 director seats on the World Stroke Organisation (WSO) board after a global vote by 3,500 members across 95 countries. She will represent the Asia‑Oceania region for a four‑year term from 2026 to 2030.
Key Takeaways (मुख्य बिंदु)
- Dr. P. Vijaya elected to WSO Board
- Will represent Asia‑Oceania region
- Four‑year term: 2026‑2030
Dr. P. Vijaya, director of the Ankineedu Advanced Stroke Centre at Lalitha PVS Institute of Medical Sciences in Guntur, has been chosen as a director on the World Stroke Organisation (WSO) Board. The election involved 3,500 members from 95 countries, with only 18 director slots available.
Why This Matters
The World Stroke Organisation is the premier global body dedicated to reducing the worldwide burden of stroke through prevention, treatment, rehabilitation, research, and education. By securing a seat, Dr. Vijaya not only achieves a personal milestone but also places India’s stroke‑care expertise at the heart of global decision‑making, especially for the fast‑growing Asia‑Oceania region.
Dr. Vijaya’s Track Record
Over the past decade, Dr. Vijaya has been instrumental in advancing clinical stroke services, pioneering research projects, and spearheading public‑awareness campaigns across Andhra Pradesh. Her work includes developing region‑specific treatment protocols, training hundreds of neurologists, and publishing influential papers in high‑impact journals.
Role on the WSO Board
From 2026 to 2030, she will help shape the organisation’s global vision, draft international stroke guidelines, and launch educational initiatives aimed at both clinicians and the public. Her responsibilities also cover overseeing worldwide stroke programmes, fostering collaboration among national stroke societies, and amplifying capacity‑building efforts in low‑resource settings.
Implications for India and the World
Dr. Vijaya’s election signals a growing recognition of India’s contributions to stroke research and care. It is likely to encourage more Indian clinicians to seek leadership roles in international bodies, facilitating knowledge exchange and joint research ventures. Moreover, her presence on the board will bring critical insights from a country that faces one of the highest stroke incidences globally, potentially influencing policies that benefit underserved populations worldwide.
Next Steps
The newly‑elected board will convene its first meeting in Seoul, South Korea, in October 2026. Dr. Vijaya will use this platform to advocate for stronger regional representation, enhanced funding for stroke prevention, and innovative rehabilitation strategies tailored to diverse healthcare systems.
